Univariate Cox regression analysis for all causes of death at discharge (1-month period)
| . | Effect* . | Hazard ratio . | 95% CI . | P-value* . |
|---|---|---|---|---|
| Type of endocarditis | PM/ICD | 0.80 | 0.53–1.20 | 0.08 |
| Prosthesis+Repair | 1.21 | 0.97–1.52 | ||
| Age (per 10 years) | 1.10 | 1.04–1.18 | 0.002 | |
| Gender | Female | 1.15 | 0.92–1.44 | 0.216 |
| Charlson index | 1.14 | 1.11–1.17 | <0.0001 | |
| Creatinine >2 mg/dL | 2.53 | 2.01–3.19 | <0.0001 | |
| Staphylococcus aureus | 1.36 | 1.04–1.74 | 0.008 | |
| Congestive heart failure | 2.90 | 2.31–3.64 | <0.0001 | |
| Vegetation length > 10 mm | 2.44 | 1.93–3.08 | <0.0001 | |
| Cerebral complication | 2.62 | 2.02–3.41 | <0.0001 | |
| Abscess | 1.71 | 1.29–2.27 | 0.0002 | |
| ESC countries | 1.12 | 0.86–1.46 | 0.42 | |
| Source of infection | Non-nosocomial | 1.35 | 0.95–1.93 | 0.0007 |
| Nosocomial | 1.68 | 1.27–2.21 | ||
| Indication—surgery performed | Indication—not performed | 4.02 | 3.06–5.27 | <0.0001 |
| Indication—performed | 0.72 | 0.54–0.97 | ||
| Type of centres | High-volume centres | 1.13 | 0.74–1.71 | 0.57 |
| Transferred from another hospital | 0.75 | 0.60–0.95 | 0.02 |
| . | Effect* . | Hazard ratio . | 95% CI . | P-value* . |
|---|---|---|---|---|
| Type of endocarditis | PM/ICD | 0.80 | 0.53–1.20 | 0.08 |
| Prosthesis+Repair | 1.21 | 0.97–1.52 | ||
| Age (per 10 years) | 1.10 | 1.04–1.18 | 0.002 | |
| Gender | Female | 1.15 | 0.92–1.44 | 0.216 |
| Charlson index | 1.14 | 1.11–1.17 | <0.0001 | |
| Creatinine >2 mg/dL | 2.53 | 2.01–3.19 | <0.0001 | |
| Staphylococcus aureus | 1.36 | 1.04–1.74 | 0.008 | |
| Congestive heart failure | 2.90 | 2.31–3.64 | <0.0001 | |
| Vegetation length > 10 mm | 2.44 | 1.93–3.08 | <0.0001 | |
| Cerebral complication | 2.62 | 2.02–3.41 | <0.0001 | |
| Abscess | 1.71 | 1.29–2.27 | 0.0002 | |
| ESC countries | 1.12 | 0.86–1.46 | 0.42 | |
| Source of infection | Non-nosocomial | 1.35 | 0.95–1.93 | 0.0007 |
| Nosocomial | 1.68 | 1.27–2.21 | ||
| Indication—surgery performed | Indication—not performed | 4.02 | 3.06–5.27 | <0.0001 |
| Indication—performed | 0.72 | 0.54–0.97 | ||
| Type of centres | High-volume centres | 1.13 | 0.74–1.71 | 0.57 |
| Transferred from another hospital | 0.75 | 0.60–0.95 | 0.02 |
P-value corresponds to the results of Wald test. For Region: the reference is North America; For type of endocarditis: Native; For indication—Surgery performed: No indication; For countries: Non-ESC; For type of centres: Low level IE; For source of infection: Community.
ICD, intracardiac defibrillator; PM, pacemaker.
Univariate Cox regression analysis for all causes of death at discharge (1-month period)
| . | Effect* . | Hazard ratio . | 95% CI . | P-value* . |
|---|---|---|---|---|
| Type of endocarditis | PM/ICD | 0.80 | 0.53–1.20 | 0.08 |
| Prosthesis+Repair | 1.21 | 0.97–1.52 | ||
| Age (per 10 years) | 1.10 | 1.04–1.18 | 0.002 | |
| Gender | Female | 1.15 | 0.92–1.44 | 0.216 |
| Charlson index | 1.14 | 1.11–1.17 | <0.0001 | |
| Creatinine >2 mg/dL | 2.53 | 2.01–3.19 | <0.0001 | |
| Staphylococcus aureus | 1.36 | 1.04–1.74 | 0.008 | |
| Congestive heart failure | 2.90 | 2.31–3.64 | <0.0001 | |
| Vegetation length > 10 mm | 2.44 | 1.93–3.08 | <0.0001 | |
| Cerebral complication | 2.62 | 2.02–3.41 | <0.0001 | |
| Abscess | 1.71 | 1.29–2.27 | 0.0002 | |
| ESC countries | 1.12 | 0.86–1.46 | 0.42 | |
| Source of infection | Non-nosocomial | 1.35 | 0.95–1.93 | 0.0007 |
| Nosocomial | 1.68 | 1.27–2.21 | ||
| Indication—surgery performed | Indication—not performed | 4.02 | 3.06–5.27 | <0.0001 |
| Indication—performed | 0.72 | 0.54–0.97 | ||
| Type of centres | High-volume centres | 1.13 | 0.74–1.71 | 0.57 |
| Transferred from another hospital | 0.75 | 0.60–0.95 | 0.02 |
| . | Effect* . | Hazard ratio . | 95% CI . | P-value* . |
|---|---|---|---|---|
| Type of endocarditis | PM/ICD | 0.80 | 0.53–1.20 | 0.08 |
| Prosthesis+Repair | 1.21 | 0.97–1.52 | ||
| Age (per 10 years) | 1.10 | 1.04–1.18 | 0.002 | |
| Gender | Female | 1.15 | 0.92–1.44 | 0.216 |
| Charlson index | 1.14 | 1.11–1.17 | <0.0001 | |
| Creatinine >2 mg/dL | 2.53 | 2.01–3.19 | <0.0001 | |
| Staphylococcus aureus | 1.36 | 1.04–1.74 | 0.008 | |
| Congestive heart failure | 2.90 | 2.31–3.64 | <0.0001 | |
| Vegetation length > 10 mm | 2.44 | 1.93–3.08 | <0.0001 | |
| Cerebral complication | 2.62 | 2.02–3.41 | <0.0001 | |
| Abscess | 1.71 | 1.29–2.27 | 0.0002 | |
| ESC countries | 1.12 | 0.86–1.46 | 0.42 | |
| Source of infection | Non-nosocomial | 1.35 | 0.95–1.93 | 0.0007 |
| Nosocomial | 1.68 | 1.27–2.21 | ||
| Indication—surgery performed | Indication—not performed | 4.02 | 3.06–5.27 | <0.0001 |
| Indication—performed | 0.72 | 0.54–0.97 | ||
| Type of centres | High-volume centres | 1.13 | 0.74–1.71 | 0.57 |
| Transferred from another hospital | 0.75 | 0.60–0.95 | 0.02 |
P-value corresponds to the results of Wald test. For Region: the reference is North America; For type of endocarditis: Native; For indication—Surgery performed: No indication; For countries: Non-ESC; For type of centres: Low level IE; For source of infection: Community.
ICD, intracardiac defibrillator; PM, pacemaker.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
